Clinical evaluation of Tribrissen. New antibacterial agent for dogs and cats.
D000818:Animals; D001424:Bacterial Infections / Q000188:drug therapy / Q000662:veterinary*; D002371:Cat Diseases / Q000188:drug therapy*; D002415:Cats; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D004338:Drug Combinations; D013411:Sulfadiazine / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use*
D004338:Drug Combinations; D013411:Sulfadiazine; D014295:Trimethoprim